Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age28+
SponsorCentre Hospitalier Universitaire de la Guadeloupe
About this trial
: Encephalitis or myelitis is defined as the inflammatory or infectious involvement of the cerebral parenchyma or spinal cord. When an infectious origin is suspected, the germ is not always identified. Next-generation sequencing could be used to correct an etiological diagnosis of these severe conditions in Guadeloupe. The rate of cases for which the infectious agent is not identified encourages continued diagnostic efforts, with the objective of identifying new pathogens or emerging pathogens, some of which may be more specific in the tropics.
Eligibility criteria
Qualifiers
Patient of at least 28 days of life
With acute onset of symptoms for more than 24 hours
a disorder of consciousness or alertness
memory disorder
Disqualifiers
Primary vasculitis of the central nervous system or a documented specific impairment in an autoimmune condition
Cerebral thrombophlebitis if not associated with encephalitis
Meningitis without clinical or paraclinical argument for cerebral parenchymal involvement
Pyogenic abscess
Trial design
Treatments tested in this trial
- Not listed
Trial groups
100 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov